Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 4, 2006, Pages 481-488

  Borody, T J ^a,b   Pang, G ^a,b   Wettstein, A R ^a   Clancy, R ^b   Herdman, K ^a   Surace, R ^a   Llorente, R ^a   Ng, C ^a  

^a Centre for Digestive Disease   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; RIFABUTIN;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; ERADICATION THERAPY; FEMALE; FLU LIKE SYNDROME; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; LETHARGY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; PATIENT; PRIORITY JOURNAL; SIDE EFFECT; THROMBOCYTOPENIA; THRUSH; UNSPECIFIED SIDE EFFECT;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BENZIMIDAZOLES; CLARITHROMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; RIFABUTIN; SULFOXIDES; TREATMENT OUTCOME;

EID: 33644880796     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02793.x     Document Type: Article

References (31)

1. Howden C Hunt R Guidelines for the management of Helicobacter pylori infection Am J Gastroenterol 1998 93 2330 8
2. Malfertheiner P Megraud F O'Morain C et al. The European Helicobacter pylori Study Group, current concepts in the management of H. pylori infection - the Maastricht 2-2000 Consensus Report Aliment Pharmacol Ther 2002 16 167 80
3. Huang J Chiba N Wilkinson JM Which combination therapy can eradicate >90%Helicobacter pylori infection? A meta-analysis of amoxycillin, metronidazole, tetracycline, and clarithromycin containing regimens Gastroenterology 1997 112 A19 (Abstract)
4. Pipkin GA Williamson R Wood JR One week clarithromycin triple therapy regimens for eradication of Helicobacter pylori Aliment Pharmacol Ther 1998 12 823 37
5. Della-Monica P Lavagna A Masoero G Lombardo L Crocella L Pera A Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy Aliment Pharmacol Ther 2002 16 1269 75
6. Peitz U Sulliga M Wolle M et al. High rate of post-therapeutic resistance after failure of macrolide-nitroimindazole triple therapy to cue Helicobacter pylori infection: impact of two second-line therapies in a randomised study Aliment Pharmacol Ther 2002 16 315 24
7. Pilotto A Franceschi M Rassau M et al. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures of after 1-week proton pump inhibitor-based triple therapies: a prospective study Dig Liver Dis 2000 32 667 72
8. Toracchio S M Marzio L Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002 Dig Liver Dis 2003 35 541 5
9. Wang W Wong B Mukhopadhyay A et al. High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong Aliment Pharmacol Ther 2000 14 901 10
10. Perez-Aldana L Kato M Nagagawa M et al. The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance Helicobacter 2002 7 306 9
11. Duck WM Sibel J Pruckler JM et al. Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States Emerg Infect Dis 2004 10 1088 94
12. Grove D Koutsouridis G Increasing resistance of Helicobacter pylori to clarithromycin: is the horse bolting Pathology 2002 34 71 3
13. Wong WM Gu Q Lam SK et al. Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection Aliment Pharmacol Ther 2003 17 553 60
14. Perri F Festa V Clemente R Quitadamo R Andruilli A Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens Aliment Pharmacol Ther 2000 14 311 6
15. Bock H Koop H Lehn N Heep M Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment: a preliminary experience J Clin Gastroenterol 2000 31 222 5
16. Gisbert J Pajares J Helicobacter pylori'rescue' regimen when proton pump inhibitor-based triple therapies fail Aliment Pharmacol Ther 2002 6 1047 57
17. Heep M Beck D Bayerdorffer E Lehn N Rifampin and rifabutin resistance mechanism in Helicobacter pylori Antimicrob Agents Chemother 1999 43 1497 9
18. Perri F Festa V Andriulli A Treatment of antibiotic resistant Helicobacter pylori infection N Engl J Med 1998 339 53
19. Gisbert J Calvet X Bujanda L Marcos S Gisbert J Pajares J 'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures Helicobacter 2003 8 90 4
20. Perri F Festa V Clemente R Villani M Quitadamo M Caruso N Randomized study of two 'rescue' therapies for Helicobacter pylori-infected patients after failure of standard triple therapies Am J Gastroenterol 2001 96 58 62
21. Bigard MA Delchier JC Raichi G Thibault P Barthelemy P One-week triple therapy using omeprazole, amoxicillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin Aliment Pharmacol Ther 1998 12 383 8
22. Wong BCY Chang FY Abid S et al. Triple therapy with clarithromycin, omeprazole and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa Aliment Pharmacol Ther 2000 14 1529 35
23. Perri F Villani MR Feta V Quitadamo M Andriulli A Predictors of failure of Helicobacter pylori eradication after the standard 'Maastricht triple therapy' Aliment Pharmacol Ther 2001 15 1023 9
24. Nagahara A Miwa H Okura R et al. Strategy for re-treatment of therapeutic failure of eradication of Helicobacter pylori infection J Gastroenterol Hepatol 2001 16 613 8
25. Gisbert J Gisbert J Marcos S et al. Seven day rescue therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate. tetracycline and metronidazole Aliment Pharmacol Ther 1999 13 1311 6
26. Lee J Breslin N Hyde D Buckley DK O'Morain CA Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice Aliment Pharmacol Ther 1999 13 489 96
27. Gisbert JP Boixeda D Mermajo F et al. Re-treatment after Helicobacter pylori eradication failure Eur J Gastroenterol Hepatol 1999 11 1049 54
28. Gomollon F Ducons JA Ferroro M et al. Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases Helicobacter 1999 4 222 5
29. Boixeda D Bermejo F Martin-De-Argila C et al. Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment of Helicobacter pylori infection Aliment Pharmacol Ther 2002 16 1457 60
30. Laine L Hunt R El-Zimaity H et al. Bismuth-base quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole and tetracycline given with omeprazole vs. omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial Am J Gastroenterol 2003 98 562 7
31. Qasim A Sebastian S Thornton O et al. Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients Aliment Pharmacol Ther 2005 21 91 6